Continuous Renal Replacement Therapy (CRRT) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Continuous Renal Replacement Therapy Market
The continuous renal replacement therapy market size was valued at USD 1.04 billion in 2023, and the market is now projected to grow from USD 1.12 billion in 2024 to USD 2.07 billion by 2032, exhibiting a CAGR of 7.9% during the forecast period of 2024-2032.
The pandemic boosted the market. This turned into due to the huge percentage of COVID-19 patients who had acute renal harm and required ICU hospitalization. As this approach is mechanically hired for patients admitted to the ICIJ, growing ICU admissions brought about expanded demand for CRRT items and offerings. However, the market's boom fee in 2021 changed into decrease because of reduced adoption of this medicinal drug among COVID-19 patients. In 2022, the market saw a dip in call for CRRT products due to a decrease in COVID-19-associated AKI patients, ensuing in negative increase. The continuous renal replacement therapy market growth is predicted to boom steadily at some stage in the projected period.
The global increase in intensive/critical care unit admissions has fueled the expansion of the renal replacement treatment industry. Acute renal damage is a prevalent consequence in intensive care units and a major public concern worldwide. This treatment significantly improves the care of critically unwell patients. This medicinal drug is best to be had in intensive care units for sufferers with acute renal damage resulting from different severe troubles together with cancer, diabetes, or coronary heart surgery. It can be administered for twenty-four hours or longer depending at the affected person's scientific condition.
As era advances, healthcare experts increasingly prefer Continuous Venovenous Hemodiafiltration (CWHDF) as a therapy alternative. Continuous Venovenous Hemodiafiltration (CWHDF) is gaining popularity for managing critically sick patients with acute renal damage because to its several benefits. This method offers advantages such as improved hemodynamic stability compared to IHD, continuous elimination of uremic toxins and fluid, and more.
Comprehensive Analysis of Continuous Renal Replacement Therapy Market
The market for Acute Kidney Injury (AKI) treatment is divided into systems and consumables, with the consumables phase accounting for the very best marketplace share in 2023. This is due to lower charges, frequent purchases, and the COVID-19 pandemic's elevated call for. Key gamers are that specialize in new product launches and regulatory approvals to fulfill marketplace needs. The structures phase is expected to develop because of higher demand for advanced systems in developed international locations. Leading players are introducing superior merchandise to tap into untapped marketplace opportunities. The market is segmented into Continuous Venovenous Hemodiafiltration (CWHDF), Slow Continuous Ultra Filtration (SCUF), Continuous Venovenous Hemodialysis (CWHD), and Continuous Venovenous Hemodiafiltration. CWHDF is the preferred modality in developed countries, while SCUF and CWHD are expected to see growth.
The North America region lead the continuous renal replacement therapy market share by benefitting a market size of USD 0.40 billion in 2023 due to the region's dominance stems from high rates of acute kidney injury (AKI) among ICU patients, higher demand for therapy-related items, and developed healthcare infrastructure. The region's large market share is supported by increased regulatory backing and a strong presence of product makers. In April 2022, Baxter International Inc. acquired 510(k) approval from the US Food and Drug Administration for their ST Set, which is utilized in this treatment. The gadget is compatible with both PrisMax and Prismaflex control units.
In 2023, key companies Baxter, Fresenius Medical Care AG & Co. KGaA (Germany), and B Braun SE dominate the market. These main businesses are increasing their product offerings and forming strategic collaborations with healthcare providers to reach a larger client base.
In December 2023, Cheshire Medical Center, a Dartmouth Health affiliate, began providing Continuous Renal Replacement Therapy (CRRT) for ICIJ patients with renal failure.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 7.9% from 2024-2032
Unit Value (USD billion)
Segmentation ByProduct Type
Systems
Consumables
- Dialysates
- Replacement Solutions
- Filters
- Catheters
- Others
By Modality
Slow Continuous Ultra Filtration (SCUF)
Continuous Venovenous Hemofiltration (CVVH)
Continuous Venovenous Hemodialysis (CVVHD)
Continuous Venovenous Hemodiafiltration (CVVHDF)
By Region
North America (By Product Type, By Modality, By Country)
- U.S.
- Canada
Europe (By Product Type, By Modality, By Country/Sub-Region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
Asia Pacific (By Product Type, By Modality, By Country/Sub-Region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
Latin America (By Product Type, By Modality, By Country/Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa (By Product Type, By Modality, By Country/Sub-Region)
- South Africa
- GCC
- Rest of Middle East & Africa
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Emerging Trends
- 4. Key Insights
- 4.1. Overview of the Parent/Related Markets
- 4.2. Industry SWOT Analysis
- 4.3. Supply Chain and Regulatory Analysis
- 4.4. Recent Industry Developments - Policies, Partnerships, New Product Launches, and Mergers & Acquisitions
- 4.5. Market Analysis and Insights (in Relation with COVID-19)
- 5. Global Skincare Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Key Findings / Summary
- 5.2. Market Size Estimates and Forecast
- 5.2.1. By Product (Value)
- 5.2.1.1. Creams
- 5.2.1.2. Lotions
- 5.2.1.3. Powders
- 5.2.1.4. Others
- 5.2.2. By Packaging Type (Value)
- 5.2.2.1. Tube
- 5.2.2.2. Bottle
- 5.2.2.3. Jar
- 5.2.2.4. Others
- 5.2.3. By Gender (Value)
- 5.2.3.1. Men
- 5.2.3.2. Women
- 5.2.4. By Distribution Channel (Value)
- 5.2.4.1. Cosmetic Stores
- 5.2.4.2. Supermarkets/Hypermarkets
- 5.2.4.3. Online/e-commerce Channels
- 5.2.4.4. Others
- 5.2.5. By Region (Value)
- 5.2.5.1. North America
- 5.2.5.2. Europe
- 5.2.5.3. Asia Pacific
- 5.2.5.4. South America
- 5.2.5.5. Middle East & Africa
- 6. North America Skincare Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Key Findings / Summary
- 6.2. Market Size Estimates and Forecast
- 6.2.1. By Product (Value)
- 6.2.1.1. Creams
- 6.2.1.2. Lotions
- 6.2.1.3. Powders
- 6.2.1.4. Others
- 6.2.2. By Packaging Type (Value)
- 6.2.2.1. Tube
- 6.2.2.2. Bottle
- 6.2.2.3. Jar
- 6.2.2.4. Others
- 6.2.3. By Gender (Value)
- 6.2.3.1. Men
- 6.2.3.2. Women
- 6.2.4. By Distribution Channel (Value)
- 6.2.4.1. Cosmetic Stores
- 6.2.4.2. Supermarkets/Hypermarkets
- 6.2.4.3. Online/e-commerce Channels
- 6.2.4.4. Others
- 6.2.5. By Country (Value)
- 6.2.5.1. U.S
- 6.2.5.1.1. By Product (Value)
- 6.2.5.1.1.1. Creams
- 6.2.5.1.1.2. Lotions
- 6.2.5.1.1.3. Powders
- 6.2.5.1.1.4. Others
- 6.2.5.2. Canada
- 6.2.5.2.1. By Product (Value)
- 6.2.5.2.1.1. Creams
- 6.2.5.2.1.2. Lotions
- 6.2.5.2.1.3. Powders
- 6.2.5.2.1.4. Others
- 6.2.5.3. Mexico
- 6.2.5.3.1. By Product (Value)
- 6.2.5.3.1.1. Creams
- 6.2.5.3.1.2. Lotions
- 6.2.5.3.1.3. Powders
- 6.2.5.3.1.4. Others
- 7. Europe Skincare Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Key Findings / Summary
- 7.2. Market Size Estimates and Forecast
- 7.2.1. By Product (Value)
- 7.2.1.1. Creams
- 7.2.1.2. Lotions
- 7.2.1.3. Powders
- 7.2.1.4. Others
- 7.2.2. By Packaging Type (Value)
- 7.2.2.1. Tube
- 7.2.2.2. Bottle
- 7.2.2.3. Jar
- 7.2.2.4. Others
- 7.2.3. By Gender (Value)
- 7.2.3.1. Men
- 7.2.3.2. Women
- 7.2.4. By Distribution Channel (Value)
- 7.2.4.1. Cosmetic Stores
- 7.2.4.2. Supermarkets/Hypermarkets
- 7.2.4.3. Online/e-commerce Channels
- 7.2.4.4. Others
- 7.2.5. By Country (Value)
- 7.2.5.1. Germany
- 7.2.5.1.1. By Product (Value)
- 7.2.5.1.1.1. Creams
- 7.2.5.1.1.2. Lotions
- 7.2.5.1.1.3. Powders
- 7.2.5.1.1.4. Others
- 7.2.5.2. France
- 7.2.5.2.1. By Product (Value)
- 7.2.5.2.1.1. Creams
- 7.2.5.2.1.2. Lotions
- 7.2.5.2.1.3. Powders
- 7.2.5.2.1.4. Others
- 7.2.5.3. Italy
- 7.2.5.3.1. By Product (Value)
- 7.2.5.3.1.1. Creams
- 7.2.5.3.1.2. Lotions
- 7.2.5.3.1.3. Powders
- 7.2.5.3.1.4. Others
- 7.2.5.4. U.K.
- 7.2.5.4.1. By Product (Value)
- 7.2.5.4.1.1. Creams
- 7.2.5.4.1.2. Lotions
- 7.2.5.4.1.3. Powders
- 7.2.5.4.1.4. Others
- 7.2.5.5. Spain
- 7.2.5.5.1. By Product (Value)
- 7.2.5.5.1.1. Creams
- 7.2.5.5.1.2. Lotions
- 7.2.5.5.1.3. Powders
- 7.2.5.5.1.4. Others
- 7.2.5.6. Rest of Europe
- 7.2.5.6.1. By Product (Value)
- 7.2.5.6.1.1. Creams
- 7.2.5.6.1.2. Lotions
- 7.2.5.6.1.3. Powders
- 7.2.5.6.1.4. Others
- 8. Asia Pacific Skincare Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Key Findings / Summary
- 8.2. Market Size Estimates and Forecast
- 8.2.1. By Product (Value)
- 8.2.1.1. Creams
- 8.2.1.2. Lotions
- 8.2.1.3. Powders
- 8.2.1.4. Others
- 8.2.2. By Packaging Type (Value)
- 8.2.2.1. Tube
- 8.2.2.2. Bottle
- 8.2.2.3. Jar
- 8.2.2.4. Others
- 8.2.3. By Gender (Value)
- 8.2.3.1. Men
- 8.2.3.2. Women
- 8.2.4. By Distribution Channel (Value)
- 8.2.4.1. Cosmetic Stores
- 8.2.4.2. Supermarkets/Hypermarkets
- 8.2.4.3. Online/e-commerce Channels
- 8.2.4.4. Others
- 8.2.5. By Country (Value)
- 8.2.5.1. China
- 8.2.5.1.1. By Product (Value)
- 8.2.5.1.1.1. Creams
- 8.2.5.1.1.2. Lotions
- 8.2.5.1.1.3. Powders
- 8.2.5.1.1.4. Others
- 8.2.5.2. India
- 8.2.5.2.1. By Product (Value)
- 8.2.5.2.1.1. Creams
- 8.2.5.2.1.2. Lotions
- 8.2.5.2.1.3. Powders
- 8.2.5.2.1.4. Others
- 8.2.5.3. Japan
- 8.2.5.3.1. By Product (Value)
- 8.2.5.3.1.1. Creams
- 8.2.5.3.1.2. Lotions
- 8.2.5.3.1.3. Powders
- 8.2.5.3.1.4. Others
- 8.2.5.4. Australia
- 8.2.5.4.1. By Product (Value)
- 8.2.5.4.1.1. Creams
- 8.2.5.4.1.2. Lotions
- 8.2.5.4.1.3. Powders
- 8.2.5.4.1.4. Others
- 8.2.5.5. Rest of Asia Pacific
- 8.2.5.5.1. By Product (Value)
- 8.2.5.5.1.1. Creams
- 8.2.5.5.1.2. Lotions
- 8.2.5.5.1.3. Powders
- 8.2.5.5.1.4. Others
- 9. South America Skincare Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Key Findings / Summary
- 9.2. Market Size Estimates and Forecast
- 9.2.1. By Product (Value)
- 9.2.1.1. Creams
- 9.2.1.2. Lotions
- 9.2.1.3. Powders
- 9.2.1.4. Others
- 9.2.2. By Packaging Type (Value)
- 9.2.2.1. Tube
- 9.2.2.2. Bottle
- 9.2.2.3. Jar
- 9.2.2.4. Others
- 9.2.3. By Gender (Value)
- 9.2.3.1. Men
- 9.2.3.2. Women
- 9.2.4. By Distribution Channel (Value)
- 9.2.4.1. Cosmetic Stores
- 9.2.4.2. Supermarkets/Hypermarkets
- 9.2.4.3. Online/e-commerce Channels
- 9.2.4.4. Others
- 9.2.5. By Country (Value)
- 9.2.5.1. Brazil
- 9.2.5.1.1. By Product (Value)
- 9.2.5.1.1.1. Creams
- 9.2.5.1.1.2. Lotions
- 9.2.5.1.1.3. Powders
- 9.2.5.1.1.4. Others
- 9.2.5.2. Argentina
- 9.2.5.2.1. By Product (Value)
- 9.2.5.2.1.1. Creams
- 9.2.5.2.1.2. Lotions
- 9.2.5.2.1.3. Powders
- 9.2.5.2.1.4. Others
- 9.2.5.3. Rest of South America
- 9.2.5.3.1. By Product (Value)
- 9.2.5.3.1.1. Creams
- 9.2.5.3.1.2. Lotions
- 9.2.5.3.1.3. Powders
- 9.2.5.3.1.4. Others
- 10. Middle East & Africa Skincare Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Key Findings / Summary
- 10.2. Market Size Estimates and Forecast
- 10.2.1. By Product (Value)
- 10.2.1.1. Creams
- 10.2.1.2. Lotions
- 10.2.1.3. Powders
- 10.2.1.4. Others
- 10.2.2. By Packaging Type (Value)
- 10.2.2.1. Tube
- 10.2.2.2. Bottle
- 10.2.2.3. Jar
- 10.2.2.4. Others
- 10.2.3. By Gender (Value)
- 10.2.3.1. Men
- 10.2.3.2. Women
- 10.2.4. By Distribution Channel (Value)
- 10.2.4.1. Cosmetic Stores
- 10.2.4.2. Supermarkets/Hypermarkets
- 10.2.4.3. Online/e-commerce Channels
- 10.2.4.4. Others
- 10.2.5. By Country (Value)
- 10.2.5.1. South Africa
- 10.2.5.1.1. By Product (Value)
- 10.2.5.1.1.1. Creams
- 10.2.5.1.1.2. Lotions
- 10.2.5.1.1.3. Powders
- 10.2.5.1.1.4. Others
- 10.2.5.2. UAE
- 10.2.5.2.1. By Product (Value)
- 10.2.5.2.1.1. Creams
- 10.2.5.2.1.2. Lotions
- 10.2.5.2.1.3. Powders
- 10.2.5.2.1.4. Others
- 10.2.5.3. Saudi Arabia
- 10.2.5.3.1. By Product (Value)
- 10.2.5.3.1.1. Creams
- 10.2.5.3.1.2. Lotions
- 10.2.5.3.1.3. Powders
- 10.2.5.3.1.4. Others
- 10.2.5.4. Rest of Middle East & Africa
- 10.2.5.4.1. By Product (Value)
- 10.2.5.4.1.1. Creams
- 10.2.5.4.1.2. Lotions
- 10.2.5.4.1.3. Powders
- 10.2.5.4.1.4. Others
- 11. Competitive Matrix
- 11.1. Business Strategies Adopted by Leading Players
- 11.2. Global Skincare Market Revenue Share/Ranking Analysis, By Key Manufacturer
- 12. Company Profiles
- 12.1. L’Oréal Professional
- 12.1.1. Overview
- 12.1.2. Description
- 12.1.3. Product Portfolio
- 12.1.4. Financials (Data as available in public domain and/or on paid databases)
- 12.1.5. Recent Developments
- 12.2. Unilever
- 12.2.1. Overview
- 12.2.2. Description
- 12.2.3. Product Portfolio
- 12.2.4. Financials (Data as available in public domain and/or on paid databases)
- 12.2.5. Recent Developments
- 12.3. Procter & Gamble
- 12.3.1. Overview
- 12.3.2. Description
- 12.3.3. Product Portfolio
- 12.3.4. Financials (Data as available in public domain and/or on paid databases)
- 12.3.5. Recent Developments
- 12.4. Estée Lauder Inc.
- 12.4.1. Overview
- 12.4.2. Description
- 12.4.3. Product Portfolio
- 12.4.4. Financials (Data as available in public domain and/or on paid databases)
- 12.4.5. Recent Developments
- 12.5. Beiersdorf AG
- 12.5.1. Overview
- 12.5.2. Description
- 12.5.3. Product Portfolio
- 12.5.4. Financials (Data as available in public domain and/or on paid databases)
- 12.5.5. Recent Developments
- 12.6. Shiseido Co., Ltd.
- 12.6.1. Overview
- 12.6.2. Description
- 12.6.3. Product Portfolio
- 12.6.4. Financials (Data as available in public domain and/or on paid databases)
- 12.6.5. Recent Developments
- 12.7. Coty Inc.
- 12.7.1. Overview
- 12.7.2. Description
- 12.7.3. Product Portfolio
- 12.7.4. Financials (Data as available in public domain and/or on paid databases)
- 12.7.5. Recent Developments
- 12.8. Natura & Co.
- 12.8.1. Overview
- 12.8.2. Description
- 12.8.3. Product Portfolio
- 12.8.4. Financials (Data as available in public domain and/or on paid databases)
- 12.8.5. Recent Developments
- 12.9. Kao Corporation
- 12.9.1. Overview
- 12.9.2. Description
- 12.9.3. Product Portfolio
- 12.9.4. Financials (Data as available in public domain and/or on paid databases)
- 12.9.5. Recent Developments
- 12.10. Johnson & Johnson Services, Inc.
- 12.10.1. Overview
- 12.10.2. Description
- 12.10.3. Product Portfolio
- 12.10.4. Financials (Data as available in public domain and/or on paid databases)
- 12.10.5. Recent Developments
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook